PolyActiva Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $40M

  • Investors
  • 7

PolyActiva General Information

Description

Developer of drug-polymer conjugates designed for site-specific drug delivery from medical device components. The company offers a delivery platform that can carry sufficient drug products of small size and still deliver therapeutic daily doses to the therapeutic site over extended periods from implants, films, or fibers, enabling healthcare organizations to provide effective drug treatments to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 21
  • 45-47 Normanby Road
  • Notting Hill, Victoria 3168
  • Australia
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • Unit 21
  • 45-47 Normanby Road
  • Notting Hill, Victoria 3168
  • Australia

PolyActiva Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PolyActiva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series C) 30-May-2025 $40M Completed Clinical Trials - Phase 2
9. Grant 07-May-2024 Completed Clinical Trials - Phase 2
8. Later Stage VC 12-Jan-2024 Completed Clinical Trials - Phase 2
7. Later Stage VC 22-Jul-2021 Completed Clinical Trials - Phase 2
6. Accelerator/Incubator Completed Clinical Trials - Phase 2
5. Later Stage VC 23-Jul-2019 Completed Clinical Trials - Phase 2
4. Later Stage VC 01-Jul-2017 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 19-Feb-2013 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 23-Jan-2012 $1.03M $1.03M Completed Clinical Trials - Phase 2
1. Joint Venture 01-Jan-2011 Completed Clinical Trials - Phase 2
To view PolyActiva’s complete valuation and funding history, request access »

PolyActiva Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
CONVERTIBLE SHARES - 2023-A
CONVERTIBLE SHARES - 2023-C
CONVERTIBLE SHARES - 2023-B
Class B 23,741,774 $1.22 $1.22 1x $1.22 62.32%
SERIES A PREFERENCE SHARES 1,000,000 $0.68 $0.68 1x $0.68 2.62%
To view PolyActiva’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PolyActiva Patents

PolyActiva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024904242-A0 Implant and method of implant administration Pending 20-Dec-2024
AU-2024904241-A0 Quinolone-polymer conjugate and composition for delivery of quinolones Pending 20-Dec-2024
AU-2022901938-A0 Implant and method of implant administration Pending 12-Jul-2022
AU-2022901937-A0 Quinolone-polymer conjugate and composition for delivery of quinolones Pending 12-Jul-2022
AU-2021902224-A0 Implant and method of implant administration Pending 19-Jul-2021
To view PolyActiva’s complete patent history, request access »

PolyActiva Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PolyActiva Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Reconstruction Fund Corporation Government Minority
Brandon Biocatalyst Venture Capital Minority
Yuuwa Venture Capital Minority
Brandon Capital Venture Capital Minority
Bionic Ear Institute Corporation Majority
You’re viewing 5 of 7 investors. Get the full list »

PolyActiva FAQs

  • When was PolyActiva founded?

    PolyActiva was founded in 2010.

  • Where is PolyActiva headquartered?

    PolyActiva is headquartered in Notting Hill, Australia.

  • What is the size of PolyActiva?

    PolyActiva has 20 total employees.

  • What industry is PolyActiva in?

    PolyActiva’s primary industry is Drug Delivery.

  • Is PolyActiva a private or public company?

    PolyActiva is a Private company.

  • What is PolyActiva’s current revenue?

    The current revenue for PolyActiva is .

  • How much funding has PolyActiva raised over time?

    PolyActiva has raised $81.2M.

  • Who are PolyActiva’s investors?

    National Reconstruction Fund Corporation, Brandon Biocatalyst, Yuuwa, Brandon Capital, and Bionic Ear Institute are 5 of 7 investors who have invested in PolyActiva.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »